Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 71335-2471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-2471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Da593f77 0b56 4eee B348 1c503d3588db 01)

FDA Label Image

Label (Lbl713352471)

Label (Lbl713352471)
The text provides information on an orally disintegrating tablet containing 30 mg of Mirtazapine, USP. It includes storage instructions, a mention of controlled room temperature, and advice for pharmacists to dispense the medication guide to each patient. The package insert QR code is referenced for the usual dosage information. The text also details the number of tablets in the package (30 tablets) and provides the names of the repackaging and manufacturing companies: Bryant Ranch Prepack, Inc. and Square Pharmaceuticals Ltd, respectively. Additionally, it advises keeping the medication out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.